» Articles » PMID: 20007571

Asynchronous RAG-1 Expression During B Lymphopoiesis

Overview
Journal J Immunol
Date 2009 Dec 17
PMID 20007571
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in cell surface markers and patterns of gene expression are commonly used to construct sequences of events in hematopoiesis. However, the order may not be as rigid as once thought and it is unclear which changes represent the best milestones of differentiation. We developed a fate-mapping model where cells with a history of RAG-1 expression are permanently marked by red fluorescence. This approach is valuable for appreciating lymphoid-lineage relationships without need for irradiation and transplantation. Hematopoietic stem cells (HSC) as well as myeloid and dendritic cell progenitors were unlabeled. Also as expected, most previously identified RAG-1(+) early lymphoid progenitors in bone marrow and all lymphoid-affiliated cells were marked. Of particular interest, there was heterogeneity among canonical common lymphoid progenitors (CLP) in bone marrow. Labeled CLP expressed slightly higher levels of IL-7Ralpha, displayed somewhat less c-Kit, and generated CD19(+) lymphocytes faster than the unlabeled CLP. Furthermore, CLP with a history of RAG-1 expression were much less likely to generate dendritic and NK cells. The RAG-1-marked CLP were lineage stable even when exposed to LPS, while unlabeled CLP were redirected to become dendritic cells in response to this TLR4 ligand. These findings indicate that essential events in B lymphopoiesis are not tightly synchronized. Some progenitors with increased probability of becoming lymphocytes express RAG-1 while still part of the lineage marker-negative Sca-1(+)c-Kit(high) (LSK) fraction. Other progenitors first activate this locus after c-Kit levels have diminished and cell surface IL-7 receptors are detectable.

Citing Articles

RAG suppresses group 2 innate lymphoid cells.

Ver Heul A, Mack M, Zamidar L, Tamari M, Yang T, Trier A bioRxiv. 2024; .

PMID: 38712036 PMC: 11071423. DOI: 10.1101/2024.04.23.590767.


C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.

Barberi T, Cui C, Friedman A PLoS One. 2020; 15(12):e0244161.

PMID: 33332417 PMC: 7746190. DOI: 10.1371/journal.pone.0244161.


The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development.

Leung G, Cool T, Valencia C, Worthington A, Beaudin A, Forsberg E Development. 2019; 146(14).

PMID: 31332039 PMC: 6679362. DOI: 10.1242/dev.176180.


At the intersection of DNA damage and immune responses.

Bednarski J, Sleckman B Nat Rev Immunol. 2019; 19(4):231-242.

PMID: 30778174 PMC: 6438741. DOI: 10.1038/s41577-019-0135-6.


PU.1 Is Required for the Developmental Progression of Multipotent Progenitors to Common Lymphoid Progenitors.

Pang S, de Graaf C, Hilton D, Huntington N, Carotta S, Wu L Front Immunol. 2018; 9:1264.

PMID: 29942304 PMC: 6005176. DOI: 10.3389/fimmu.2018.01264.


References
1.
Serwold T, Ehrlich L, Weissman I . Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. Blood. 2008; 113(4):807-15. PMC: 4123410. DOI: 10.1182/blood-2008-08-173682. View

2.
Balciunaite G, Ceredig R, Massa S, Rolink A . A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol. 2005; 35(7):2019-30. DOI: 10.1002/eji.200526318. View

3.
Montecino-Rodriguez E, Leathers H, Dorshkind K . Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006; 7(3):293-301. DOI: 10.1038/ni1301. View

4.
Manz M, Traver D, Miyamoto T, Weissman I, Akashi K . Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood. 2001; 97(11):3333-41. DOI: 10.1182/blood.v97.11.3333. View

5.
Mansson R, Zandi S, Anderson K, Martensson I, Jacobsen S, Bryder D . B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. Blood. 2008; 112(4):1048-55. DOI: 10.1182/blood-2007-11-125385. View